A total of 40 solid organ transplant patients underwent colonic biopsy for gastrointestinal symptoms during the study period, of which 32 patients were taking mycophenolate mofetil at the time of ...

Patients with dermatologic conditions showed a 74% lower risk for malignancy with mycophenolate mofetil (MMF) than transplant patients, a study found. Researchers conducted a single-center ...

After transplantation of cells, tissues, or organs, it is important to control inflammation to prevent graft rejection. This can be difficult as continuous injuries due to chronic rejection can pose ...

In a new analysis of the BLISS LN trial, researchers added Belimumab (Benlysta) to Mycophenolate (MMF), the standard of care treatment for lupus nephritis, (LN, lupus-related kidney disease) and found ...